Prognosis prediction based on methionine metabolism genes signature in gliomas
Abstract Background Glioma cells have increased intake and metabolism of methionine, which can be monitored with 11 C-L-methionine. However, a short half-life of 11 C (~ 20 min) limits its application in clinical practice. It is necessary to develop a methionine metabolism genes-based prediction mod...
Main Authors: | Sujin Zhou, Xianan Zhao, Shiwei Zhang, Xue Tian, Xuepeng Wang, Yunping Mu, Fanghong Li, Allan Z. Zhao, Zhenggang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-023-01754-x |
Similar Items
-
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients
by: Zewei Tu, et al.
Published: (2021-01-01) -
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
by: Chuming Tao, et al.
Published: (2020-02-01) -
A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
by: Yi Zhou, et al.
Published: (2023-11-01) -
Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas
by: Penggang Sun, et al.
Published: (2023-02-01) -
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)